Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid (CB), which interacts with specific targets involved in carcinogenesis. Specifically, CBG potently blocks transient receptor ...

A team of German researchers recently conducted a study examining lesser-known cannabinoids cannabigerol and cannabichromene and their effects on lung cancer cells.

A family-owned hemp farm in Lawrence, Kansas specializing in CBG (cannabigerol). Lab-tested, seed-to-shelf, retail and wholesale CBG products ready to ship.

A combination of the cannabinoid cannabigerol (CBG) and certain terpenes significantly reduced DNA damage, oxidative stress and genomic instability caused by components of gastric reflux … Continue re...

A new study published in Antioxidants found that the cannabinoids cannabigerol (CBG) and cannabichromene (CBC) induced cell death and apoptosis in two lung cancer cell lines, suggesting the compounds ...

Naturally occurring chemicals in cannabis have been shown to reduce cholesterol–and the risk of deadly fatty liver disease, says new research.

Cannabigerol (CBG) produced antipsychotic-like effects across multiple behavioral tests in mouse models of schizophrenia, according to a new study published in Progress in Neuro-Psychopharmacology and...

Several cannabis plant-derived compounds, especially cannabinoids, exhibit therapeutic potential in numerous diseases and conditions. In particular, THC and CBD impart palliative, antiemetic, as well ...

Researchers at Washington State University found that cannabigerol (CBG) reduces anxiety and improves verbal memory without causing intoxication or impairments in healthy adults.

Eine neue wissenschaftliche Studie des Instituts für Pharmakologie und Toxikologie am Universitätsklinikum Rostock hat gezeigt, dass CBG (Cannabigerol) und CBC (Cannabichromen), zwei weniger bekannte ...

Cannabigerol (CBG) is a rare cannabinoid derived from the cannabis plant. Learn more about CBG, including how it works, its potential benefits, and its side effects.

New research published in Free Radical Biology and Medicine found that cannabigerol (CBG) may have strong anti-cancer effects against pancreatic cancer cells, with researchers saying the compound slow...

Eine neue präklinische Studie von Forschern des Rambam Health Care Campus legt nahe, dass CBG (Cannabigerol) ein vielversprechender Kandidat für die Behandlung von rheumatoider Arthritis (PR) werden k...

A lesser known cannabis component known as CBG could represent a novel treatment in the treatment of rheumatoid arthritis (RA), according to a new study. Researchers at the Rambam Health Care Campus in Israel released preclinical findings from a study examining cannabigerol, a non-intoxicating cannabinoid, and its potential to reduce inflammation associated with arthritis. While most conventional RA therapies target certain proteins called cytokines, the study authors described using CBG to directly regulate white blood cells, or neutrophils, that can release certain cytokines linked to inflammation. The research findings were recently published in the journal Pharmaceuticals.

Research shows that non-psychoactive compounds in the cannabis plant, such as CBD, CBG, and CBN, could provide a safer alternative to pain therapy than the drugs currently used